Morgan Stanley’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.7M | Sell |
|
|||||
|
2025
Q1 | $15.5M | Sell |
|
|||||
|
2024
Q4 | $35.3M | Buy |
|
|||||
|
2024
Q3 | $28.1M | Sell |
|
|||||
|
2024
Q2 | $51.2M | Sell |
|
|||||
|
2024
Q1 | $39.2M | Sell |
|
|||||
|
2023
Q4 | $27M | Buy |
|
|||||
|
2023
Q3 | $7.39M | Buy |
|
|||||
|
2023
Q2 | $12.2M | Sell |
|
|||||
|
2023
Q1 | $19.2M | Buy |
|
|||||
|
2022
Q4 | $22.7M | Buy |
|
|||||
|
2022
Q3 | $1.31M | Sell |
|
|||||
|
2022
Q2 | $1.95M | Buy |
|
|||||
|
2022
Q1 | $2.02M | Buy |
|
|||||
|
2021
Q4 | $1.78M | Sell |
|
|||||
|
2021
Q3 | $3.03M | Buy |
|
|||||
|
2021
Q2 | $2.52M | Sell |
|
|||||
|
2021
Q1 | $3.41M | Buy |
|
|||||
|
2020
Q4 | $1.72M | Buy |
|
|||||
|
2020
Q3 | $142K | Buy |
|